LBA19 Event-free survival (EFS) analysis of neoadjuvant taxane/carboplatin with or without atezolizumab followed by an adjuvant anthracycline regimen in high-risk triple negative breast cancer (TNBC): NeoTRIP Michelangelo randomized study
- Authors:
- L Gianni, C Huang, D Egle, B Bermejo, C Zamagni, M Thill, AA Torres, G Bianchini, ES Fernandez, S Russo, EM Ciruelos, R Greil, V Semiglazov, MA Colleoni, CM Kelly, G Mariani, L Del Mastro, R Spezia, H Ali, G Viale
- Journal:
- Annals of Oncology
- Citation info:
- 34:s1258-s1259
- Publication date:
- 1st Oct 2023
- Full text
- DOI